Medical condition
Alk Positive Nsclc
Alk Positive Nsclc is a medical condition tracked by NovaPharmaNews across 3 associated drugs and ongoing industry coverage. Explore approved and pipeline therapies, regulatory status, and the latest developments.
Associated drugs & therapies
- tislelizumab (TEVIMBRA) Antineoplastic and immunomodulating agents (L01)
- atezolizumab (TECENTRIQ) Antineoplastic and immunomodulating agents (L01)
- alectinib (ALECENSA) Antineoplastic and immunomodulating agents (L01)